Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Reviews on Recent Clinical Trials
  4. Fast Track Articles
  5. Fast Track Article
image of The Association between Gallstone Disease and Incidence of Cardiovascular Disease: A Systematic Review and Meta-Analysis

Abstract

Background

Gallstone Disease (GSD) is a multifactorial risk factor for various complications.

Objective

This study aimed to examine the relationship between GSD and Cardiovascular Disease (CVD) incidence through a systematic review and meta-analysis approach.

Methods

A thorough search was conducted across Web of Science, Scopus, MEDLINE/PubMed, Cochrane Library, and Embase databases. Only studies published between 1980 and December 2023 were included. Chi-square, I2, and forest plots were used to assess heterogeneity. Begg's and Egger's tests were used to evaluate publication bias. Statistical significance was considered at <0.05, and all analyses were performed using Stata 17.

Results

This meta-analysis involved 21 studies and comprised 2,138,282 participants; there has been a significant association found between GSD and an increased risk of CVD (with a relative risk of 1.46, 95% confidence interval: 1.32-1.63, <0.001). The analysis found no evidence of publication bias based on Begg's test ( =0.085) and Egger's test ( =0.231). Subgroup analysis of the studies showed a higher risk of CVD in studies with a sample size of less than 10,000 participants, conducted in 2016 or later, utilizing a cross-sectional design, in Asian countries; the analysis had a moderate quality score, with a follow-up period of equal to or less than ten years.

Conclusion

There has been a significant association found between GSD and an increased risk of incidence of CVD. Taking proactive steps to implement targeted interventions for individuals with gallstone disease could potentially reduce the risk of cardiovascular disease within this population.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/rrct/10.2174/0115748871326450240926072451
2024-10-08
2024-11-26

  • From This Site

    /content/journals/rrct/10.2174/0115748871326450240926072451
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Lüscher T.F. Novel risk markers and mediators in coronary disease and stroke. Eur. Heart J. 2015 36 25 1557 1559 10.1093/eurheartj/ehv218 26136055
    [Google Scholar]
  2. Jones M.W. Weir C.B. Ghassemzadeh S. Gallstones (Cholelithiasis). StatPearls StatPearls Publishing Treasure Island (FL) 2023 29083691
    [Google Scholar]
  3. Nimanya S. Ocen W. Makobore P. Bua E. Ssekitooleko B. Oyania F. Prevalence and risk factors of gallstone disease in patients undergoing ultrasonography at Mulago hospital, Uganda. Afr. Health Sci. 2020 20 1 383 391 10.4314/ahs.v20i1.44 33402926
    [Google Scholar]
  4. Song S.T. Shi J. Wang X.H. Guo Y.B. Hu P.F. Zhu F. Zeng X. Xie W.F. Prevalence and risk factors for gallstone disease: A population‐based cross‐sectional study. J. Dig. Dis. 2020 21 4 237 245 10.1111/1751‑2980.12857 32166900
    [Google Scholar]
  5. Fairfield C.J. Wigmore S.J. Harrison E.M. Gallstone disease and the risk of cardiovascular disease. Sci. Rep. 2019 9 1 5830 10.1038/s41598‑019‑42327‑2 30967586
    [Google Scholar]
  6. Patel A.M. Yeola M. Mahakalkar C. Demographic and risk factor profile in patients of gallstone disease in Central India. Cureus 2022 14 5 e24993 10.7759/cureus.24993 35719762
    [Google Scholar]
  7. Roth G.A. Mensah G.A. Johnson C.O. Global burden of cardiovascular diseases and risk factors, 1990–2019. J. Am. Coll. Cardiol. 2020 76 25 2982 3021 10.1016/j.jacc.2020.11.010 33309175
    [Google Scholar]
  8. Masoumi S. Separham A. Parizad R. Jafarisis S. Assefi M. Dual left anterior descending artery: Clinical overview and interventional management. J. Tehran Univ. Heart Cent. 2023 18 2 146 150 10.18502/jthc.v18i2.13326 37637287
    [Google Scholar]
  9. Amirabbas Rostami Torabi S.M. Masoumi S. Poudineh M. Poudineh S. Rabori V.S. The crosstalk between coronary artery bypass grafting and miRNAs. Biol. Bull. Russ. Acad. Sci. 2023 50 6 1167 1171 10.1134/S1062359023602082
    [Google Scholar]
  10. Kodali N.K. Bhat L.D. Phillip N.E. Koya S.F. Prevalence and associated factors of cardiovascular diseases among men and women aged 45 years and above: Analysis of the longitudinal ageing study in India, 2017–2019. Indian Heart J. 2023 75 1 31 35 10.1016/j.ihj.2022.12.003 36549638
    [Google Scholar]
  11. Adhikary D. Barman S. Ranjan R. Stone H. A systematic review of major cardiovascular risk factors: A growing global health concern. Cureus 2022 14 10 e30119 10.7759/cureus.30119 36381818
    [Google Scholar]
  12. Teo K.K. Rafiq T. Cardiovascular risk factors and prevention: A perspective from developing countries. Can. J. Cardiol. 2021 37 5 733 743 10.1016/j.cjca.2021.02.009 33610690
    [Google Scholar]
  13. Upala S. Sanguankeo A. Jaruvongvanich V. Gallstone disease and the risk of cardiovascular disease: A systematic review and meta-analysis of observational studies. Scand. J. Surg. 2017 106 1 21 27 10.1177/1457496916650998 27255283
    [Google Scholar]
  14. Lv J. Qi L. Yu C. Guo Y. Bian Z. Chen Y. Yang L. Shen J. Wang S. Li M. Liu Y. Zhang L. Chen J. Chen Z. Li L. Gallstone disease and the risk of ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 2015 35 10 2232 2237 10.1161/ATVBAHA.115.306043 26272939
    [Google Scholar]
  15. Paul O. Lepper M.H. Phelan W.H. Dupertuis G.W. MacMillan A. McKean H. Park H. A longitudinal study of coronary heart disease. Circulation 1963 28 1 20 31 10.1161/01.CIR.28.1.20 13941964
    [Google Scholar]
  16. Seddighi S. Ghidari M.E. Sadeghi A. Shahrbaf M.A. Mahmanzar M.A. Saadati S. Yari Z. Evaluation of the cardiovascular risk in patients with biliary stones: A descriptive cross-sectional study. Gastroenterol. Hepatol. Bed Bench 2018 11 Suppl. 1 S14 S19 30774802
    [Google Scholar]
  17. Chen L. Yang H. Li H. He C. Yang L. Lv G. Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study. Hepatology 2022 75 4 785 796 10.1002/hep.32183 34624136
    [Google Scholar]
  18. Fu Q. Shen T. Yu Q. Jiang L. Yang R. Causal effect of gallstone disease on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization study. Sci. Rep. 2023 13 1 18807 10.1038/s41598‑023‑46117‑9 37914780
    [Google Scholar]
  19. Zhang L. Zhang W. He L. Cui H. Wang Y. Wu X. Zhao X. Yan P. Yang C. Xiao C. Tang M. Chen L. Xiao C. Zou Y. Liu Y. Yang Y. Zhang L. Yao Y. Li J. Liu Z. Yang C. Jiang X. Zhang B. Impact of gallstone disease on the risk of stroke and coronary artery disease: Evidence from prospective observational studies and genetic analyses. BMC Med. 2023 21 1 353 10.1186/s12916‑023‑03072‑6 37705021
    [Google Scholar]
  20. Petitti D.B. Wingerd J. Pellegrin F. Ramcharan S. Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA 1979 242 11 1150 1154 10.1001/jama.1979.03300110022020 470067
    [Google Scholar]
  21. Bortnichak E.A. Freeman D.H. Jr Ostfeld A.M. Castelli W.P. Kannel W.B. Feinleib M. McNamara P.M. The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am. J. Epidemiol. 1985 121 1 19 30 10.1093/oxfordjournals.aje.a113978 3155483
    [Google Scholar]
  22. Grimaldi C.H. Nelson R.G. Pettitt D.J. Sampliner R.E. Bennett P.H. Knowler W.C. Increased mortality with gallstone disease: Results of a 20-year population-based survey in Pima Indians. Ann. Intern. Med. 1993 118 3 185 190 10.7326/0003‑4819‑118‑3‑199302010‑00005 8417635
    [Google Scholar]
  23. Ruhl C.E. Everhart J.E. Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2011 140 2 508 516 10.1053/j.gastro.2010.10.060 21075109
    [Google Scholar]
  24. Jiang Z.Y. Sheng X. Xu C.Y. Li W.W. Chang X.X. Sun L.Y. Yang X.B. Yu L.F. Gallbladder gallstone disease is associated with newly diagnosed coronary artery atherosclerotic disease: A cross-sectional study. PLoS One 2013 8 9 e75400 10.1371/journal.pone.0075400 24058685
    [Google Scholar]
  25. Lee Y.S. Jang S.E. Lee B.S. Lee S.J. Lee M.G. Park J.K. Lee S.H. Ryu J.K. Kim Y.T. Yoon Y.B. Hwang J.H. Presence of coronary artery disease increases the risk of biliary events in patients with asymptomatic gallstones. J. Gastroenterol. Hepatol. 2013 28 9 1578 1583 10.1111/jgh.12275 23701468
    [Google Scholar]
  26. Olaiya M.T. Chiou H.Y. Jeng J.S. Lien L.M. Hsieh F.I. Significantly increased risk of cardiovascular disease among patients with gallstone disease: A population-based cohort study. PLoS One 2013 8 10 e76448 10.1371/journal.pone.0076448 24098504
    [Google Scholar]
  27. Wei C.Y. Chung T.C. Chen C.H. Lin C.C. Sung F.C. Chung W.T. Kung W.M. Hsu C.Y. Yeh Y.H. Gallstone disease and the risk of stroke: A nationwide population-based study. J. Stroke Cerebrovasc. Dis. 2014 23 7 1813 1820 10.1016/j.jstrokecerebrovasdis.2014.04.024 24957305
    [Google Scholar]
  28. Wirth J. Giuseppe R. Wientzek A. Katzke V.A. Kloss M. Kaaks R. Boeing H. Weikert C. Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study. Eur. J. Prev. Cardiol. 2015 22 3 326 334 10.1177/2047487313512218 24177267
    [Google Scholar]
  29. Zheng Y. Xu M. Li Y. Hruby A. Rimm E.B. Hu F.B. Wirth J. Albert C.M. Rexrode K.M. Manson J.E. Qi L. Gallstones and risk of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2016 36 9 1997 2003 10.1161/ATVBAHA.116.307507 27540264
    [Google Scholar]
  30. Shabanzadeh D.M. Sørensen L.T. Jørgensen T. Gallstone disease and mortality: A cohort study. Int. J. Public Health 2017 62 3 353 360 10.1007/s00038‑016‑0916‑7 27815564
    [Google Scholar]
  31. Wang J-Y. Lu F-H. Sun Z-J. Wu J-S. Yang Y-C. Lee C-T. Chang C-J. Gallstone disease associated with increased risk of arterial stiffness in a Taiwanese population. J. Hum. Hypertens. 2017 31 10 616 619 10.1038/jhh.2017.43 28660886
    [Google Scholar]
  32. Zheng Y. Xu M. Heianza Y. Ma W. Wang T. Sun D. Albert C.M. Hu F.B. Rexrode K.M. Manson J.E. Qi L. Gallstone disease and increased risk of mortality: Two large prospective studies in US men and women. J. Gastroenterol. Hepatol. 2018 33 11 1925 1931 10.1111/jgh.14264 29671893
    [Google Scholar]
  33. Gill E.S. Jeong Y.J. Lee J. Association between gallstone disease and ischemic stroke in Korea. Neurol. Asia 2021 26 4 649 655 10.54029/2021yjc
    [Google Scholar]
  34. Higashizono K. Nakatani E. Hawke P. Fujimoto S. Oba N. Risk factors for gallstone disease onset in Japan: Findings from the Shizuoka Study, a population-based cohort study. PLoS One 2022 17 12 e0274659 10.1371/journal.pone.0274659 36584097
    [Google Scholar]
  35. Su W. Zhu J.G. Li W.P. Chen H. Li H.W. Gallstone disease and the risk of cardiac mortality in patients with acute coronary syndrome. Front. Cardiovasc. Med. 2022 9 1033959 10.3389/fcvm.2022.1033959 36505391
    [Google Scholar]
  36. Bai R. Wang J. Yang J. Cheng X. Zhang S. Zhang H. Wu X. Ma R. Zhang X. Guo H. Peng X. Guo S. Gallbladder disease is associated with the risk of cardiovascular disease among Uyghurs in Xinjiang: A prospective cohort study. BMC Public Health 2023 23 1 242 10.1186/s12889‑023‑15098‑9 36737734
    [Google Scholar]
  37. Chae W. Lee H.S. Jo J.H. Chung M.J. Bang S. Park S.W. Song S.Y. Jang S.I. Park J.Y. Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: A nationwide population-based cohort study. Sci. Rep. 2023 13 1 7300 10.1038/s41598‑023‑33440‑4 37147417
    [Google Scholar]
  38. Konyn P. Alshuwaykh O. Dennis B.B. Cholankeril G. Ahmed A. Kim D. Gallstone disease and its association with nonalcoholic fatty liver disease, all-cause and cause-specific mortality. Clin. Gastroenterol. Hepatol. 2023 21 4 940 948.e2 10.1016/j.cgh.2022.04.043 35643414
    [Google Scholar]
  39. Fan L. Chen B. Dai Z. The relation between gallstone disease and cardiovascular disease. Sci. Rep. 2017 7 1 15104 10.1038/s41598‑017‑15430‑5 29118437
    [Google Scholar]
  40. Zhao S.F. Wang A.M. Yu X.J. Wang L.L. Xu X.N. Shi G.J. Association between gallstone and cardio‑cerebrovascular disease: Systematic review and meta‑analysis. Exp. Ther. Med. 2019 17 4 3092 3100 10.3892/etm.2019.7291 30936980
    [Google Scholar]
  41. Wang X. Yu W. Li S. Xie L. He Y. Liu Y. Li H. Jiang G. Chen X. Bai X. Gallstone disease and risk of non-communicable diseases incidence and all-cause mortality: Cumulative evidence from longitudinal studies with over 25 million participants. SSRN 4561801 10.2139/ssrn.4561801
    [Google Scholar]
  42. Völzke H. Baumeister S.E. Alte D. Hoffmann W. Schwahn C. Simon P. John U. Lerch M.M. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005 71 2 97 105 10.1159/000084525 15775677
    [Google Scholar]
  43. Almobarak A.O. Jervase A. Fadl A.A. Garelnabi N.I.A. Hakem S.A. Hussein T.M. Ahmad A.A.A. Ahmed I.S.E. Badi S. Ahmed M.H. The prevalence of diabetes and metabolic syndrome and associated risk factors in Sudanese individuals with gallstones: A cross sectional survey. Transl. Gastroenterol. Hepatol. 2020 5 15 10.21037/tgh.2019.10.09 32258518
    [Google Scholar]
  44. Haal S. Guman M.S.S. Bruin S. Schouten R. van Veen R.N. Fockens P. Dijkgraaf M.G.W. Hutten B.A. Gerdes V.E.A. Voermans R.P. Risk factors for symptomatic gallstone disease and gallstone formation after bariatric surgery. Obes. Surg. 2022 32 4 1270 1278 10.1007/s11695‑022‑05947‑8 35143012
    [Google Scholar]
  45. Wang D.Q. Cohen D.E. Carey M.C. Biliary lipids and cholesterol gallstone disease. J. Lipid Res. 2009 50 S406 S411 10.1194/jlr.R800075‑JLR200 19017613
    [Google Scholar]
  46. Desai M.S. Mathur B. Eblimit Z. Vasquez H. Taegtmeyer H. Karpen S.J. Penny D.J. Moore D.D. Anakk S. Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology 2017 65 1 189 201 10.1002/hep.28890 27774647
    [Google Scholar]
  47. Zhang R. Ma W.Q. Fu M.J. Li J. Hu C.H. Chen Y. Zhou M.M. Gao Z.J. He Y.L. Overview of bile acid signaling in the cardiovascular system. World J. Clin. Cases 2021 9 2 308 320 10.12998/wjcc.v9.i2.308 33521099
    [Google Scholar]
  48. Chiang J.Y.L. Ferrell J.M. Wu Y. Boehme S. Bile acid and cholesterol metabolism in atherosclerotic cardiovascular disease and therapy. Cardiol. Plus 2020 5 4 159 170 10.4103/2470‑7511.305419 34350368
    [Google Scholar]
  49. Wang Y. Chen B. Ciaccio E.J. Jneid H. Virani S.S. Lavie C.J. Lebovits J. Green P.H.R. Krittanawong C. Celiac disease and the risk of cardiovascular diseases. Int. J. Mol. Sci. 2023 24 12 9974 10.3390/ijms24129974 37373122
    [Google Scholar]
  50. Poddighe D. Dossybayeva K. Abdukhakimova D. Akhmaltdinova L. Ibrayeva A. Celiac disease and gallbladder: Pathophysiological aspects and clinical issues. Nutrients 2022 14 20 4379 10.3390/nu14204379 36297063
    [Google Scholar]
  51. Grigor’eva I.N. Romanova T.I. Gallstone disease and microbiome. Microorganisms 2020 8 6 835 10.3390/microorganisms8060835 32498344
    [Google Scholar]
  52. Sun H. Warren J. Yip J. Ji Y. Hao S. Han W. Ding Y. Factors influencing gallstone formation: A review of the literature. Biomolecules 2022 12 4 550 10.3390/biom12040550 35454138
    [Google Scholar]
  53. Binda C. Gibiino G. Coluccio C. Sbrancia M. Dajti E. Sinagra E. Capurso G. Sambri V. Cucchetti A. Ercolani G. Fabbri C. Biliary diseases from the microbiome perspective: How microorganisms could change the approach to benign and malignant diseases. Microorganisms 2022 10 2 312 10.3390/microorganisms10020312 35208765
    [Google Scholar]
  54. Miele L. Giorgio V. Alberelli M.A. De Candia E. Gasbarrini A. Grieco A. Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk. Curr. Cardiol. Rep. 2015 17 12 120 10.1007/s11886‑015‑0671‑z 26497040
    [Google Scholar]
  55. Witkowski M. Weeks T.L. Hazen S.L. Gut microbiota and cardiovascular disease. Circ. Res. 2020 127 4 553 570 10.1161/CIRCRESAHA.120.316242 32762536
    [Google Scholar]
  56. Murphy K. O’Donovan A.N. Caplice N.M. Ross R.P. Stanton C. Exploring the gut microbiota and cardiovascular disease. Metabolites 2021 11 8 493 10.3390/metabo11080493 34436434
    [Google Scholar]
/content/journals/rrct/10.2174/0115748871326450240926072451
Loading
The Association between Gallstone Disease and Incidence of Cardiovascular Disease: A Systematic Review and Meta-Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0115748871326450240926072451
/content/journals/rrct/10.2174/0115748871326450240926072451
/content/journals/rrct/10.2174/0115748871326450240926072451
Loading

Data & Media loading...

Supplements

file format download Download

  • Article Type:     Research Article
Keywords: Gallstone disease ; heart disease ; cholelithiasis ; cardiovascular disease

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test